23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-49.31%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-49.31%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
377.41%
Positive EBIT growth while Insurance - Life median is negative. Peter Lynch might see a strong competitive advantage in operations.
377.41%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
604.65%
Net income growth exceeding 1.5x Insurance - Life median of 15.31%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
605.04%
EPS growth exceeding 1.5x Insurance - Life median of 8.91%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
605.08%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 8.91%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.13%
Negative OCF growth while Insurance - Life median is 7.14%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-22.13%
Negative FCF growth while Insurance - Life median is 6.65%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
81.95%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 17.93%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
-11.66%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-28.73%
Negative 3Y CAGR while Insurance - Life median is -6.17%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
170.24%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 43.27% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
21.28%
OCF/share CAGR of 21.28% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
13.56%
3Y OCF/share growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm if cost advantage or brand strength explains near-term outperformance.
254.55%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 103.08% over a decade. Joel Greenblatt might see a standout compounder of earnings.
15.51%
5Y net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would check that top-line growth and share count management both contribute.
-19.91%
Negative 3Y CAGR while Insurance - Life median is -3.27%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
299.73%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 45.85% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
22.96%
5Y equity/share CAGR near Insurance - Life median. Charlie Munger finds it normal mid-term expansion for the industry.
12.36%
3Y equity/share CAGR > 1.5x Insurance - Life median of 4.15%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.41%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
8.79%
BV/share growth of 8.79% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-18.57%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
3.13%
SG&A growth of 3.13% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.